| # | Drug | Count |
|---|---|---|
| 0 | DORNASE ALFA | 1761 |
| 1 | TOBRAMYCIN | 1278 |
| 2 | ALBUTEROL SULFATE | 800 |
| 3 | PANCRELIPASE | 787 |
| 4 | SODIUM CHLORIDE | 538 |
| 5 | SODIUM CHLORIDE TABLET | 527 |
| 6 | SODIUM CHLORIDE TABLETS | 527 |
| 7 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 502 |
| 8 | TOBRAMYCIN SULFATE | 426 |
| 9 | TOBRAMYCIN SOLUTION | 414 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AQUAVIT | 1 | 0.5000 |
| 1 | DORNASE ALFA | 1761 | 0.0903 |
| 2 | SODIUM SULFACETAMIDE 9.8% AND SULFUR 4.8% | 1 | 0.0667 |
| 3 | TOBRAMYCIN | 1278 | 0.0535 |
| 4 | SODIUM SULFACETAMIDE, SULFUR | 1 | 0.0500 |
| 5 | SODIUM SULFACETAMIDE AND SULFUR | 1 | 0.0500 |
| 6 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 284 | 0.0488 |
| 7 | COLISTIMETHATE SODIUM | 67 | 0.0425 |
| 8 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 502 | 0.0405 |
| 9 | AZTREONAM | 287 | 0.0402 |
| # | Drug class | Count |
|---|---|---|
| 0 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1761 |
| 1 | Aminoglycoside Antibacterial [EPC] | 1321 |
| 2 | Osmotic Laxative [EPC] | 650 |
| 3 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 556 |
| 4 | Corticosteroid [EPC] | 495 |
| 5 | Proton Pump Inhibitor [EPC] | 444 |
| 6 | Insulin Analog [EPC] | 286 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 181 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 180 |
| 9 | Benzodiazepine [EPC] | 164 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1761 | 0.0903 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 556 | 0.0326 |
| 2 | Aminoglycoside Antibacterial [EPC] | 1321 | 0.0297 |
| 3 | Vitamin B6 Analog [EPC] | 4 | 0.0116 |
| 4 | Vitamin K [EPC] | 69 | 0.0082 |
| 5 | Monobactam Antibacterial [EPC] | 18 | 0.0067 |
| 6 | Bile Acid [EPC] | 146 | 0.0065 |
| 7 | Antihypoglycemic Agent [EPC] | 14 | 0.0034 |
| 8 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0032 |
| 9 | Cannabinoid [EPC] | 22 | 0.0028 |